Navigation Links
Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL
Date:9/26/2007

CLEARWATER, Fla., Sept. 26 /PRNewswire/ -- Advanced Bio-Technologies Inc (ABT) is pleased to announce that the majority shares in the corporation have been purchased by HealthEdge Investment Partners of Tampa FL. (http://www.healthedgepartners.com).

Paul Guilbaud, ABT President and CEO, commented, "This is a new stage in the exciting development of ABT. The acquisition allows us to ramp up sales and marketing in the USA, build the necessary infrastructure for our world- wide sales expansion and allow us to support our International distributors."

"This is a positive development for both ABT and HealthEdge. We believe that the synergy between our fund and the company will facilitate accelerated growth for the company. We intend to work closely with the management of ABT to grow the business organically and by using the infrastructure as a platform to acquire new brands," commented Brian Anderson, Managing Partner at HealthEdge Investment Partners.

Advanced Bio-Technologies is one of the leading companies in the rapidly growing global scar treatment market with its patented silicone-based products marketed under the brand Kelo-cote(R). Silicone is recognized as the first line of treatment for abnormal scars throughout the medical community. ABT has relocated its offices to Clearwater, Florida, where it will centralize the functions of the company to better manage its growth.

ABT has also launched its Kelo-cote(R) scar treatment line in the key European markets through 100%-owned subsidiaries in the UK and Germany. This strategic development allows ABT to have direct operations in some of the largest markets worldwide, and creates the platform for concentrating its efforts in the Plastic Surgery and Dermatology sectors. New products will ensure growth for ABT in each of those markets. "We have established a strong Kelo-cote(R) presence in the New York City, Los Angeles and Miami markets and are currently expanding our US sales team to reach other key metro areas including Tampa, Dallas, and Atlanta," stated Mr. Guilbaud.


'/>"/>
SOURCE Advanced Bio-Technologies Inc
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Achieving Reliable Protein Quantitation Results Using ICAT Reagents, MALDITOF Mass Spectrometry, and Advanced Data Interpretation Tool
2. Precision Testing for the Sciclone Advanced Liquid Handler Z8 Option
3. 384 Well Pipetting Precision and Accuracy Testing Using the Sciclone Advanced Liquid Handler
4. WARF expands license agreement with Advanced Cell Technology
5. Rockwells $1M gift to UWM will support advanced automation research
6. Advanced CIO: Technology execs must trumpet their success
7. FDA approves advanced digital mammography system
8. Tech Digest: Inacom; St. Michaels, St. Clares hospitals; Merge eMed; Advanced Data-Comm; Blue Cross and Blue Shield
9. Wisconsins insurance companies use advanced IT to speed relief
10. $60 Million Available in Advanced Tech Competition
11. Advanced Life Sciences to Hit the Road For $30 Million in Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):